Related references
Note: Only part of the references are listed.Lovastatin protects against cisplatin-induced hearing loss in mice
Katharine Fernandez et al.
HEARING RESEARCH (2020)
Exosomes mediate sensory hair cell protection in the inner ear
Andrew M. Breglio et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Nuclear ERK: Mechanism of Translocation, Substrates, and Role in Cancer
Galia Maik-Rachline et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier
Sophie Nyberg et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Organotypic Culture of Neonatal Murine Inner Ear Explants
Jacqueline M. Ogier et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Glucococorticoid receptor activation exacerbates aminoglycoside-induced damage to the zebrafish lateral line
Tamasen Hayward et al.
HEARING RESEARCH (2019)
Paeoniflorin protects spiral ganglion neurons from cisplatin-induced ototoxicity: Possible relation to PINK1/BAD pathway
Xiaoyu Yu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Allicin Protects against Cisplatin-Induced Stria Vascularis Damage: Possible Relation to Inhibition of Caspase-3 and PARP-1-AIF-Mediated Apoptotic Pathways
Jing Cai et al.
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY (2019)
Local Drug Delivery for Prevention of Hearing Loss
Leonard P. Rybak et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Practical approaches to evaluating and optimizing brain exposure in early drug discovery
Burgess B. Freeman et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work
Rajesh Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC)
Richard A. Ward et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies
Corne J. Kros et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
ORC-13661 protects sensory hair cells from aminoglycoside and cisplatin ototoxicity
Sian R. Kitcher et al.
JCI INSIGHT (2019)
Interventions for cisplatin-induced hearing loss in children and adolescents with cancer
David R. Freyer et al.
LANCET CHILD & ADOLESCENT HEALTH (2019)
Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study
Hege S. Haugnes et al.
ACTA ONCOLOGICA (2018)
Recent developments and obstacles in the treatment of melanoma with BRAF and MEK inhibitors
Mohd Wahid et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib
Georgina Long et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
CDK2 inhibitors as candidate therapeutics for cisplatin-and noise-induced hearing loss
Tal Teitz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss
Robert A. Hazlitt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Co-enzyme Q10 upregulates Hsp70 and protects chicken primary myocardial cells under in vitro heat stress via PKC/MAPK
Jiao Xu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss
P. R. Brock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring BRAF V600E Mutations
Lauretta Odogwu et al.
ONCOLOGIST (2018)
The Stress Response in the Non-sensory Cells of the Cochlea Under Pathological Conditions-Possible Role in Mediating Noise Vulnerability
Anni Herranen et al.
JARO-JOURNAL OF THE ASSOCIATION FOR RESEARCH IN OTOLARYNGOLOGY (2018)
Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing Loss
Robert A. Hazlitt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Targeting oncogenic Raf protein-serine/threonine kinases in human cancers
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2018)
Quinoxaline protects zebrafish lateral line hair cells from cisplatin and aminoglycosides damage
Sonia M. Rocha Sanchez et al.
SCIENTIFIC REPORTS (2018)
Cell-Specific Transcriptome Analysis Shows That Adult Pillar and Deiters' Cells Express Genes Encoding Machinery for Specializations of Cochlear Hair Cells
Huizhan Liu et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Data Descriptor: Transcriptomes of cochlear inner and outer hair cells from adult mice
Yi Li et al.
SCIENTIFIC DATA (2018)
Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience
Arjun Khunger et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2018)
Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial
David R. Freyer et al.
LANCET ONCOLOGY (2017)
Allicin protects auditory hair cells and spiral ganglion neurons from cisplatin - Induced apoptosis
Xianmin Wu et al.
NEUROPHARMACOLOGY (2017)
BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma
Heike Niessner et al.
CLINICAL CANCER RESEARCH (2017)
The Sustained- Exposure Dexamethasone Formulation OTO-104 Offers Effective Protection against Noise-Induced Hearing Loss
Anne Harrop-Jones et al.
AUDIOLOGY AND NEURO-OTOLOGY (2016)
Age-related hearing loss: prevention of threshold declines, cell loss and apoptosis in spiral ganglion neurons
Robert D. Frisina et al.
AGING-US (2016)
Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
David Planchard et al.
LANCET ONCOLOGY (2016)
Pathological Axonal Death through a MAPK Cascade that Triggers a Local Energy Deficit
Jing Yang et al.
CELL (2015)
Aging after Noise Exposure: Acceleration of Cochlear Synaptopathy in Recovered Ears
Katharine A. Fernandez et al.
JOURNAL OF NEUROSCIENCE (2015)
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss
Heng Xu et al.
NATURE GENETICS (2015)
Therapeutic Effect of Dexamethasone for Noise-induced Hearing Loss: Systemic Versus Intratympanic Injection in Mice
Min Ah Han et al.
OTOLOGY & NEUROTOLOGY (2015)
Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps
Marius Ilie et al.
CANCER MEDICINE (2015)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Population Pharmacokinetics of Dabrafenib, a BRAF Inhibitor: Effect of Dose, Time, Covariates, and Relationship With Its Metabolites
Daniele Ouellet et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
In Vivo Generation of Immature Inner Hair Cells in Neonatal Mouse Cochleae by Ectopic Atoh1 Expression
Zhiyong Liu et al.
PLOS ONE (2014)
Inner ear supporting cells protect hair cells by secreting HSP70
Lindsey A. May et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Sound preconditioning therapy inhibits ototoxic hearing loss in mice
Soumen Roy et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Time Courses of Changes in Phospho- and Total- MAP Kinases in the Cochlea after Intense Noise Exposure
Yukihide Maeda et al.
PLOS ONE (2013)
Inner ear supporting cells: Rethinking the silent majority
Guoqiang Wan et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2013)
Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors
Tara R. Rheault et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Cisplatin and Aminoglycoside Antibiotics: Hearing Loss and Its Prevention
Jochen Schacht et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2012)
Review: Ototoxic Characteristics of Platinum Antitumor Drugs
Dalian Ding et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2012)
RAS/RAF/MEK Inhibitors in Oncology
M. Broggini
CURRENT MEDICINAL CHEMISTRY (2012)
Screen of FDA-approved drug library reveals compounds that protect hair cells from aminoglycosides and cisplatin
Anna L. Vlasits et al.
HEARING RESEARCH (2012)
Quinoline Ring Derivatives Protect Against Aminoglycoside-Induced Hair Cell Death in the Zebrafish Lateral Line
Henry C. Ou et al.
JARO-JOURNAL OF THE ASSOCIATION FOR RESEARCH IN OTOLARYNGOLOGY (2012)
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
Gerald S. Falchook et al.
LANCET ONCOLOGY (2012)
Normal Hearing Sensitivity at Low-to-Middle Frequencies with 34% Prestin-Charge Density
Tetsuji Yamashita et al.
PLOS ONE (2012)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Preclinical Models for Neuroblastoma: Establishing a Baseline for Treatment
Tal Teitz et al.
PLOS ONE (2011)
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7
Narendra Wajapeyee et al.
CELL (2008)
The burdens of age-related and occupational noise-induced hearing loss in the United States
Robert A. Dobie
EAR AND HEARING (2008)
Damage-induced activation of ERK1/2 in cochlear supporting cells is a hair cell death-promoting signal that depends on extracellular ATP and calcium
Manuela Lahne et al.
JOURNAL OF NEUROSCIENCE (2008)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
Chemoresistance of endothelial cells induced by basic fibroblast growth factor depends on Raf-1-mediated inhibition of the proapoptotic kinase, ASK1
Alireza S. Alavi et al.
CANCER RESEARCH (2007)
A GFP-based genetic screen reveals mutations that disrupt the architecture of the zebrafish retinotectal projection
T Xiao et al.
DEVELOPMENT (2005)
Hearing threshold elevation precedes hair-cell loss in prestin knockout mice
XD Wu et al.
MOLECULAR BRAIN RESEARCH (2004)
Role of Raf in vascular protection from distinct apoptotic stimuli
A Alavi et al.
SCIENCE (2003)
A cochlear cell line as an in vitro system for drug ototoxicity screening
GM Kalinec et al.
AUDIOLOGY AND NEURO-OTOLOGY (2003)
Pifithrin-alpha supresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis
M Zhang et al.
NEUROSCIENCE (2003)
Share Paper
